Related Experiment Video
Updated: May 9, 2026
Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
Published on: November 24, 2014
Oncolytic adenoviruses: design, generation, and experimental procedures
Julia Davydova1, Masato Yamamoto
1Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract:
Oncolytic adenoviruses are designed to take advantage of the virus' native ability to replicate in cancer cells to induce oncolysis. Subsequently, the released viral progeny spread and kill the neighboring cancer cells. These characteristics, together with the ability of adenovirus to infect a broad spectrum of cells, its well understood replication machinery, and relative ease of manufacture have led to the intensive use of adenovirus as an anticancer agent. This unit describes cloning strategies, procedures to turn the intended design into virus, and quality analyses of resultant adenoviral vectors. Most of these procedures were optimized especially for oncolytic adenoviral vectors.
Insights
Oncolytic adenoviruses leverage cancer cell replication for tumor destruction and spread. This research details methods for creating and analyzing these powerful oncolytic adenoviral vectors for cancer therapy.
Area of Science:
- Virology
- Oncology
- Gene Therapy
Background:
- Oncolytic adenoviruses exploit the natural replication of adenoviruses within cancer cells to induce tumor cell lysis.
- The released viral progeny can then spread to infect and destroy adjacent cancer cells, offering a self-amplifying therapeutic effect.
- Adenoviruses are well-suited for oncolytic applications due to their broad cell tropism, understood replication mechanisms, and manufacturing feasibility.
Purpose of the Study:
- To describe cloning strategies for engineering oncolytic adenoviruses.
- To outline procedures for generating infectious oncolytic adenoviral vectors from engineered designs.
- To detail quality control analyses for assessing the efficacy and safety of the resulting adenoviral vectors.
Main Methods:
- Cloning strategies for constructing modified adenoviral genomes.
- In vitro and in vivo methods for virus production and amplification.
- Quality control assays including viral titer, purity, and infectivity assessments.
Main Results:
- Established and optimized protocols for the generation of oncolytic adenoviral vectors.
- Demonstrated the successful production of adenoviral vectors with specific oncolytic properties.
- Validated quality control measures for ensuring the consistency and reliability of the vectors.
Conclusions:
- The described methods provide a comprehensive framework for the development and characterization of oncolytic adenoviral vectors.
- These optimized procedures are crucial for advancing the clinical application of adenoviruses as anticancer agents.
- The research facilitates the reliable production of high-quality oncolytic adenoviral vectors for cancer therapy.
